Gains for Dr Reddy from his Distribution Partnership with Sanofi Healthcare
Dr. Reddy's Labs' Partnership Boosts
Enhances portfolio and market presence.
Deal includes popular vaccine brands.
Securing exclusive distribution pact with Sanofi Healthcare India.
Dr. Reddy's Acquires Sanofi's India Vaccine Distribution Rights
Benefits healthcare professionals and patients.
Aims to increase vaccine accessibility.
Click Here Dr. Reddy's Market Position Strengthening
Enhances the competitive pharmaceutical landscape.
Sanofi's vaccine brands were added.
Gains second position among Indian vaccine players.
CEO Ramana's Commitment to Expansion
Signals dedication to healthcare advancement.
Emphasizes Dr. Reddy's innovation.
Aims to serve 1.5 billion patients by 2030.
Company Board to Approve Q4 2024 Financial Results
Reflecting positive market response.
Meeting on May 7, 2024
Open Demat G-L92HWH8MZR